GREY WOLF THERAPEUTICS LIMITED
Research and experimental development on biotechnology
GREY WOLF THERAPEUTICS LIMITED
Research and experimental development on biotechnology
Contact & Details
Contact
Registered Address
99 Park Drive Milton Abingdon OX14 4RY England
Full company profile for GREY WOLF THERAPEUTICS LIMITED (10989365), an active life sciences and medical technology company based in Abingdon, England. Incorporated 29 Sept 2017. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Net Assets, Total Assets & Total Liabilities (2018–2024)
Cash in Bank
£20.42M
Net Assets
£26.29M
Total Liabilities
£2.61M
Turnover
N/A
Employees
19
Debt Ratio
9%
Financial History
Revenue, profit, EBITDA and key financial figures
2024 31 Dec Year End | 2023 31 Dec Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
Investors (7)
| Investor Name | Investor Since | Participating Rounds |
|---|---|---|
| Investor 1 | Feb 2019 | Series A, Series B |
| Investor 2 | Feb 2019 | Series A, Series B |
| Investor 4 | Jan 2023 | Series B |
See all 7 investors
Sign up to view complete investor information
Officers
Officers
| Status | |||||
|---|---|---|---|---|---|
| Ahrens, Brenton Karl | Director | American | United States | 29 Mar 2018 | Active |
| Hercend, Thierry, Dr | Director | French | France | 29 Mar 2018 | Active |
| Joyce, Peter | Director | British | England | 29 Sept 2017 | Active |
See all 16 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (0)
Thomas David Mccarthy
Ceased 29 Mar 2018
Peter Joyce
Ceased 29 Mar 2018
Canaan Xi L.p.
Ceased 12 Feb 2019
Biodiscovery 5 Fpci
Ceased 12 Feb 2019
Group Structure
Group Structure
No group structure identified
Charges
Charges
No charges registered
Properties
Properties
No related properties
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 1 May 2026 | Capital | Capital Cancellation Shares | |
| 1 May 2026 | Capital | Capital Cancellation Shares | |
| 24 Apr 2026 | Officers | Appointment of Mr Edwin Moses as director on 16 Apr 2026 | |
| 11 Mar 2026 | Resolution | Resolutions | |
| 11 Mar 2026 | Incorporation | Memorandum Articles |
Capital Cancellation Shares
Capital Cancellation Shares
Appointment of Mr Edwin Moses as director on 16 Apr 2026
Resolutions
Memorandum Articles
Recent Activity
Latest Activity
Capital Cancellation Shares
1 months ago on 1 May 2026
Capital Cancellation Shares
1 months ago on 1 May 2026
Appointment of Mr Edwin Moses as director on 16 Apr 2026
1 months ago on 24 Apr 2026
Resolutions
2 months ago on 11 Mar 2026
Memorandum Articles
2 months ago on 11 Mar 2026